Lv1
96 积分 2022-04-27 加入
A non-randomized phase 2 trial of pembrolizumab in untreated patients with carcinoma of unknown primary site
13天前
已完结
An investigative meta-analysis on the effectiveness and safety of integrating VEGF/VEGFR inhibitors with PD-1/PD-L1 inhibitors in cases with R/M HNSCC
1个月前
已完结
A phase 1/1b study of lenvatinib and cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma
1个月前
已完结
Pembrolizumab Plus Quad-Shot Radiotherapy for Recurrent, Unresectable, or Metastatic Head and Neck Cancer: A Nonrandomized Clinical Trial
1个月前
已完结
Becotatug vedotin for recurrent/metastatic nasopharyngeal carcinoma (Magic-M001): a multicenter, randomized trial
1个月前
已完结
Head and Neck Cancer: A Review
1个月前
已完结
Randomized Phase III and Extension Studies of Naldemedine in Patients With Opioid-Induced Constipation and Cancer
1个月前
已完结
Sequencing antibody–drug conjugates in metastatic breast cancer: A systematic review
3个月前
已完结
Advancing Antibody-Drug Conjugates: Current Perspectives and Future Directions
3个月前
已完结
Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial
5个月前
已完结
皖公网安备34019202002308
